Prostate cancer
Conditions
Interventions
Gold Standard:Pathology
Index test:PSMA PET-MRI
Sponsors
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. 30 patients aged 18 to 85 years; 2. Patients with elevated PSA or other conditions that need to be considered for prostate cancer (refer to 2020 NCCN guidelines and 2014 Chinese guidelines), or patients with biochemical recurrence after radical prostatectomy (PSA>0.2) Good compliance; 3. Agree to participate in this clinical trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Concomitant cancers; 2. Contraindications to MRI examination; 3. Implantation of functional electronic devices and various stimulators in the body, such as pacemakers, cochlear implants, cardiac stents, and implants made of ferromagnetic materials (such as iron, cobalt, Nickel, etc.); 4. Perfusion devices implanted in the body, such as insulin or other perfusion pumps; 5. surgery within the past 3 months, especially those with organ transplantation, heart or kidney surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PSMA PET/MRI; | — |
Countries
China
Contacts
Public ContactLu Chen
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Outcome results
None listed